Ledger.Open graph →
SEC Form D · filed January 23, 2025

ZETAGEN THERAPEUTICS, INC

Offering
$6.2M
Sold
$83K
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
SYRACUSE, NY
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (18)

Nikhil Thakur, Md · Andover, MAExec · DirectorPeter B. Finn · Boston, MAExecRichard C. Warburg · Bethesda, MDDirectorAshok C. Kaveeshwar · Bethesda, MDDirectorJoe C. Loy · Weatherford, TXExec · DirectorDonald C. Brown · Hopkinton, MADirectorMichael D. Hankin · Baltimore, MDDirectorMichael J. Stark · Menlo Park, CADirectorRobert Poulin · Arlington, VAExec · DirectorWilliam O. White · Baltimore, MDDirectorNicholas Bienstock · New York, NYExec · DirectorHans Miller · Arlington, VAExecAndrew Levin · Boston, MAExecJoshua Resnick · Boston, MAExec · DirectorGregory M. Gentile · New York, NYExec · DirectorSteven Sordello · New York, NYDirectorTodd Crow · Portland, ORDirectorSteve Wolin · Minneapolis, MNDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗